[1] LEJEUNE J,LAFOURCADE J,BERGER R,et al.3 cases of partial deletion of the short arm of a 5 chromosome[J].C R Hebd Seances Acad Sci,1963(257):3098-3102. [2] CERRUTI MAINARDI P.Cri du Chat syndrome[J].Orphanet J Rare Dis,2006(1):33. [3] HIGURASHI M,ODA M,ⅡJIMA K,et al.Livebirth prevalence and follow-up of malformation syndromes in 27,472 newborns[J].Brain Dev,1990,12(6):770-773. [4] HU H,LIU H,PENG C,et al.Clinical experience of non-invasive prenatal chromosomal aneuploidy testing in 190,277 patient samples[J].Curr Mol Med,2016,16(8):759-766. [5] LIU Y,LIU H,HE Y,et al.Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21,18,13 and sex chromosome aneuploidy in a pilot city in China[J].Hum Genomics,2020,14(1):21. [6] SRINIVASAN A,BIANCHI D W,HUANG H,et al.Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma[J].Am J Hum Genet,2013,92(2):167-176. [7] HU H,WANG L,WU J,et al.Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies[J].Hum Genomics,2019,13(1):14. [8] LIANG D,CRAM D S,TAN H,et al.Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes[J].Genet Med,2019,21(9):1998-2006. [9] SHI P,WANG Y,LIANG H,et al.The potential of expanded noninvasive prenatal screening for detection of microdeletion and microduplication syndromes[J].Prenat Diagn,2021,41(10):1332-1342. [10] YIN A H,PENG C F,ZHAO X,et al.Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA[J].Proc Natl Acad Sci USA,2015,112(47):14670-14675. [11] LIAO C,YIN A H,PENG C F,et al.Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing[J].Proc Natl Acad Sci USA,2014,111(20):7415-7420. [12] CHIU R W,AKOLEKAR R,ZHENG Y W,et al.Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing:Large scale validity study[J].BMJ,2011(342):c7401. [13] LO Y M,CORBETTA N,CHAMBERLAIN P F,et al.Presence of fetal DNA in maternal plasma and serum[J].Lancet,1997,350(9076):485-487. [14] DENNIS LO Y M.Noninvasive fetal whole-genome sequencing from maternal plasma:Feasibility studies and future directions[J].Clin Chem,2013,59(4):601-603. [15] AMBERGER J S,BOCCHINI C A,SCOTT A F,et al.OMIM.org:Leveraging knowledge across phenotype-gene relationships[J].Nucleic Acids Res,2019,47(D1):D1038-D1043. [16] PENG Y,PANG J,HU J,et al.Clinical and molecular characterization of 12 prenatal cases of Cri-du-chat syndrome[J].Mol Genet Genomic Med,2020,8(8):e1312. [17] SUZUMORI N,SEKIZAWA A,TAKEDA E,et al.Retrospective details of false-positive and false-negative results in non-invasive prenatal testing for fetal trisomies 21,18 and 13[J].Eur J Obstet Gynecol Reprod Biol,2021(256):75-81. [18] MARDY A,WAPNER R J.Confined placental mosaicism and its impact on confirmation of NIPT results[J].Am J Med Genet C Semin Med Genet,2016,172(2):118-122. [19] DEL G F,YUAN V,ROBINSON W P.Confined placental mosaicism involving multiple de novo copy number variants associated with fetal growth restriction:A case report[J].Am J Med Genet A,2021,185(6):1908-1912. [20] DEL G F,YIN Y,CHOUFANI S,et al.Genomic imbalances in the placenta are associated with poor fetal growth[J].Mol Med,2021,27(1):3. [21] YUAN X,YONG W,DAI L,et al.The role of non-invasive prenatal testing and ultrasound in prenatal screening of fetal chromosomal abnormalities in singleton:A retrospective study[J].Ann Transl Med,2023,11(2):111. [22] ZHANG F,YIN T,TANG X,et al.Prenatal diagnosis of a case with complete and uniform tetrasomy 12p by the utility of noninvasive prenatal testing[J].J Assist Reprod Genet,2023,40(9):2233-2240. [23] ZOU Y,FENG C,QIN J,et al.Performance of expanded non-invasive prenatal testing for fetal aneuploidies and copy number variations:A prospective study from a single center in Jiangxi province,China[J].Front Genet,2022(13):1073851. [24] ZHANG M,TANG J,LI J,et al.Value of noninvasive prenatal testing in the detection of rare fetal autosomal abnormalities[J].Eur J Obstet Gynecol Reprod Biol,2023(284):5-11. [25] TIAN W,YUAN Y,YUAN E,et al.Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication[J].Eur J Med Res,2023,28(1):304. [26] WANG C,MEI L,WAN Y,et al.Clinical value of positive CNVs results by NIPT without fetal ultrasonography-identified structural anomalies[J].Mol Genet Genomic Med,2024,12(1):e2352. [27] CASTRO C P D,GÓMEZ-GONZÁLEZ C,RODRÍGUEZ-LÓPEZ R,et al.Prenatal diagnosis commission and the genetics commission of the Spanish society of laboratory medicine.Prenatal genetic diagnosis of monogenic diseases[J].Adv Lab Med.2023;4(1):28-51. [28] 唐国一,杨红梅,杨恺欣,等.GDM患者妊娠中期血糖异常项数及妊娠晚期血糖指标与妊娠结局的关系[J].广州医药,2024,55(3):316-323. [29] ZHEN J,GU Y,WANG P,et al.Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits[J].Diabetologia,2024,67(4):703-713. [30] FAAS BHW,ASTUTI G,MELCHERS WJG,et al.Early detection of active Human CytomegaloVirus(hCMV)infection in pregnant women using data generated for noninvasive fetal aneuploidy testing[J].EBioMedicine,2024(100):104983. [31] TONG X,YU X,DU Y,et al.Peripheral Blood Microbiome Analysis via Noninvasive Prenatal Testing Reveals the Complexity of Circulating Microbial Cell-Free DNA.Microbiol Spectr.2022;10(3):e0041422. [32] ELDEM V,KURALAY SC,ÖZDOĞAN G,et al.Comprehensive analysis of circulating viral DNA in maternal plasma at population-scale using low-pass whole-genome sequencing.Genomics.2023;115(2):110556. |